Purpose:The aim was to investigate the effect of Nd:YAG capsulotomy on refraction, intraocular pressure and anterior chamber depth changes and complications of Nd:YAG laser treatment for posterior capsular opacification in pseudophakic eyes. Methods: Our study includes 26 eyes (23 patients) with posterior capsular opacification after uncomplicated phacoemulsification surgery and intraocular lens implantation. Complete ocular examinations were performed for all patients. The visual acuity, intraocular pressure and anterior chamber depth measurements were obtained in all examinations. Nd:YAG capsulotomy was measured in all patients. Eyes received one drop of aproclonidine 0.5 % before and immediately after YAG laser capsulotomy. Data were analysed statistically. Results: Mean patient age was 53.73 Ϯ 13.53 years. Before Nd:YAG capsulotomy mean anterior chamber depth was 4.03 Ϯ 0.58 mm and in the first day after capsulotomy the mean value was 4.02 Ϯ 0.46 mm. Mean spherical equivalent refraction before laser treatment was -0.52 D and on the first day after laser treatment was -0.49 D. An improvement in visual acuity was achieved in all cases. Before Nd:YAG capsulotomy mean visual acuity was 0.38 Ϯ 0.13 and on the first day after capsulotomy, the mean value was 0.93 Ϯ 0.11, the difference of which was statistically significant. There were no statistically significant differences between the anterior chamber depth and intraocular pressure measurements before laser capsulotomy and on the first day, first month and third month after laser. Conclusion: Nd:YAG laser capsulotomy is an effective and safe method of treatment of posterior capsular opacification.

Rose K lenses are a viable alternative in the visual rehabilitation of patients with keratoconus.

Phacoemulsification power should be kept at minimum in order to induce minimal trauma and to achieve early rehabilitation.

There is a temporary therapeutic effect of posterior subtenon's triamcinolone injection without laser photocoagulation. GLP improves VA and reduces the risk of recurrent macular edema after posterior STTA injection.

Purpose:To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher.Design:Prospective, randomized clinical trial.Participants: Twenty-eight patients.Methods:Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient.Results:Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment.Conclusion:A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg.